{"result": "(\"entity\"<|>CANADIAN TASK FORCE<|>ORGANIZATION<|>The Canadian Task Force is an institution that published a classification of levels of evidence and corresponding grades of recommendation for clinical practice guidelines.)\n##\n(\"entity\"<|>CENTRE FOR EVIDENCE BASED MEDICINE<|>ORGANIZATION<|>The Centre for Evidence Based Medicine in Oxford provides classifications of scientific evidence types for clinical practice guidelines.)\n##\n(\"entity\"<|>AGENCY FOR HEALTHCARE RESEARCH AND QUALITY<|>ORGANIZATION<|>The Agency for Healthcare Research and Quality (AHQR) developed guidelines that utilize a classification system for levels of evidence.)\n##\n(\"entity\"<|>AMERICAN SOCIETY OF PARENTERAL AND ENTERAL NUTRITION<|>ORGANIZATION<|>The American Society of Parenteral and Enteral Nutrition (ASPEN) employs a classification system for levels of evidence in their guidelines.)\n##\n(\"entity\"<|>EUROPEAN SOCIETY OF PARENTERAL AND ENTERAL NUTRITION<|>ORGANIZATION<|>The European Society of Parenteral and Enteral Nutrition (ESPEN) has developed guidelines that include a classification of evidence.)\n##\n(\"entity\"<|>NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE<|>ORGANIZATION<|>The National Institute for Health and Clinical Excellence has developed clinical practice guidelines with a hierarchical classification of evidence.)\n##\n(\"entity\"<|>SCOTTISH INTERCOLLEGIATE GUIDELINES NETWORK<|>ORGANIZATION<|>The Scottish Intercollegiate Guidelines Network (SIGN) has a classification system for levels of evidence that has been adopted by recent ESPEN guidelines.)\n##\n(\"entity\"<|>GRADE<|>ORGANIZATION<|>The GRADE system (Grading of Recommendations, Assessment, Development, and Evaluations) is a common system proposed for the classification of evidence in clinical practice guidelines.)\n##\n(\"relationship\"<|>CANADIAN TASK FORCE<|>CENTRE FOR EVIDENCE BASED MEDICINE<|>Both organizations are involved in the classification of levels of evidence for clinical practice guidelines<|>5)\n##\n(\"relationship\"<|>CANADIAN TASK FORCE<|>AGENCY FOR HEALTHCARE RESEARCH AND QUALITY<|>Both organizations have developed systems for classifying levels of evidence in clinical practice guidelines<|>5)\n##\n(\"relationship\"<|>AGENCY FOR HEALTHCARE RESEARCH AND QUALITY<|>AMERICAN SOCIETY OF PARENTERAL AND ENTERAL NUTRITION<|>AHQR's classification system is utilized in the guidelines of ASPEN<|>4)\n##\n(\"relationship\"<|>AGENCY FOR HEALTHCARE RESEARCH AND QUALITY<|>EUROPEAN SOCIETY OF PARENTERAL AND ENTERAL NUTRITION<|>AHQR's classification system is utilized in the guidelines of ESPEN<|>4)\n##\n(\"relationship\"<|>NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE<|>SCOTTISH INTERCOLLEGIATE GUIDELINES NETWORK<|>Both organizations have developed hierarchical classifications of evidence for clinical practice<|>5)\n##\n(\"relationship\"<|>GRADE<|>CANADIAN TASK FORCE<|>The GRADE system is proposed as a common system for classifying evidence, which relates to the work of the Canadian Task Force<|>3)\n##\n(\"relationship\"<|>GRADE<|>EUROPEAN SOCIETY OF PARENTERAL AND ENTERAL NUTRITION<|>The GRADE system is suggested for use in the guidelines developed by ESPEN<|>3)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: iación. La investigación clínica actual está financiada, en su mayor parte, por la industria far-\n---\nTema 59. Nutrición basada en la evidencia   931\n\nmacéutica, por lo que no pueden descartarse ses-\ngos relacionados con esto (por ejemplo, de no \npublicación de los resultados negativos).\n\nEstos motivos, entre otros, explican la escasez de es-\ntudios de buena calidad en el ámbito de la nutrición y \nla dificultad de crear guías de manejo nutricional con \naltos niveles de evidencia.\n\n## 6. La MBE y las guías de práctica clínica: niveles de evidencia y grados de recomendación\n\nLas guías de práctica clínica (GPC) son «documentos \ninformativos que incluyen recomendaciones dirigidas a \noptimizar el cuidado del paciente, en base a una revi-\nsión sistemática de la evidencia y a la evaluación de los \nbeneficios y daños de distintas opciones en la atención \na la salud»23. Se ha demostrado que la existencia de \nGPC mejora la práctica clínica.\n\nExiste gran variabilidad entre las GPC, lo cual dificul-\nta su universalización, fundamentalmente debido al \nempleo de distintos sistemas de clasificación de los ni-\nveles de evidencia. Los denominados «niveles de evi-\ndencia» permiten clasificar jerárquicamente los estu-\ndios en función del rigor científico en su diseño y, por \ntanto, según su fiabilidad y posibilidad de error. Su in-\ntención es basar las decisiones clínicas en los estudios \ncon menor probabilidad de sesgo, considerando que el \nensayo clínico prospectivo con asignación aleatoria, \ncontrolado y enmascarado, con seguimiento completo \ny analizado por «intención de tratar», es el mejor de \nlos diseños24. Los estudios prospectivos aleatorizados \n(EPA) son considerados el gold standard, por lo que en \nlas primeras clasificaciones les correspondió el mayor \nnivel de evidencia, seguidos por los no aleatorizados, \nlos estudios de cohortes y los de casos y controles, los \ncontroles históricos y las opiniones de los expertos. \nMás tarde se han incorporado los metaanálisis y las \nrevisiones sistemáticas de la literatura, por encima de \nlos EPA.\n\nEn las GPC se debe especificar siempre el tipo de cla-\nsificación de la evidencia que se ha utilizado, puesto \nque una recomendación «grado A» puede ser más o \nmenos «consistente» y estar basada en tipos de estu-\ndios de distinta calidad, según sea la clasificación em-\npleada. La primera institución que publicó una clasifi-\ncación de niveles de evidencia y sus correspondientes \ngrados de recomendación fue la Canadian Task For-\nce25, modificándola en los años 9026. Posteriormente \nhan aparecido nuevas clasificaciones de la evidencia \ncientífica, como la del Centre for Evidence Based Medi-\ncine de Oxford, que tiene en cuenta los diversos tipos \nde estudios27, o las de la Agency for Healthcare Re-\nsearch and Quality (AHQR)28, empleada en las primeras \nguías de la American Society of Parenteral and Enteral \nNutrition (ASPEN) y de la European Society of Parente-\n\nral and Enteral Nutrition (ESPEN). También el National \nInstitute for Health and Clinical Excellence ha desarro-\nllado guías de práctica clínica con su clasificación jerár-\nquica de la evidencia29. Las guías ESPEN más recientes \nhan adoptado la clasificación de la Scottish Intercolle-\ngiate Guidelines Network (SIGN)30, 31 (tabla 4).\n\nLa falta de consistencia entre los distintos sistemas \nde clasificación de niveles de evidencia es una de las \nmayores debilidades para la universalización de las \nguías de práctica clínica. En los últimos años, distintos \nautores y editores de revistas médicas vienen preconi-\nzando el uso de un sistema común, el sistema GRADE \n(Grading of Recommendations, Assessment, Develop-\nment, and Evaluations), que permita un lenguaje ho-\nmogéneo entre las distintas fuentes de guías de prácti-\nca clínica32. El sistema GRADE propone las siguientes \ndefiniciones:\n\n- Calidad de la evidencia (alta, moderada, baja y \nmuy baja): indica hasta qué punto nuestra con-\nfianza en la estimación de un efecto es adecuada \npara apoyar una recomendación y, al mismo tiem-\npo, la utilidad esperable de investigaciones futu-\nras en el tema en cuestión.\n- Fuerza de la recomendación: indica hasta qué \npunto podemos confiar si poner en práctica la re-\ncomendación conllevará más beneficios que ries-\ngos. Gradúa la fuerza de las recomendaciones en \ndos categorías (fuertes -cuando los beneficios de \nuna actuación superan a los riesgos o cuando cla-\nramente no lo hacen- o débiles -cuando la evi-\ndencia disponible es de muy baja calidad o cu\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}